卖什么
Menten AI designs peptide and protein therapeutics using quantum…
商业模式拆解
买家：谁掌握预算？
Pharma and biotech discovery/R&D leads (strategic partnerships; claims top-10 pharma partners).
触发点：什么让他们现在购买？
未核实Hard or undruggable targets, especially protein-protein interfaces where screening fails.
工作流：什么输入变成什么输出？
MAUD 1.0 designs peptide macrocycles de novo using generative AI, physics-based models and quantum simulation, then optimizes potency, permeability and oral bioavailability.
经济账：省了什么，怎么收费？
未核实Partnership/discovery-collaboration model (terms not published); claims >90% hit rate, nM potency.
渠道：怎么接触到客户？
Business-development led: "Partner with Us" contact form.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2020 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.